Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

Congress
Main Content

Therapeutic Plenary Session 1104

Management of Hyperkinetic Movement Disorders

Sunday, October 5, 2025
15:30 - 17:00 | Room TBD
Clinical

In this session, the faculty will present current treatment approaches involving medications and invasive therapies for tremor, myoclonus and Huntington’s disease.


Chairs:
Francisco Cardoso, Brazil
Marina De Koning-Tijssen, Netherlands

Presenters:

Tremor
Peter Bain, United Kingdom

Myoclonus
Emmanuel Roze, France

Huntington's Disease
John O'Sullivan, Australia

CSPC Liaisons:
Francesca Morgante, United Kingdom

Learning Objectives
At the conclusion of this session, participants should be better able to:

  1. Select appropriate medications and invasive therapies (MRgFUS, DBS) for isolated tremor syndromes
  2. Develop an evidence based treatment plan for the management of non-epileptic myoclonic syndromes
  3. Select an appropriate comprehensive management plan for Huntington’s disease, including pharmacological and non-pharmacological options

Recommended Audience
Clinician / General Neurology
Fellow / Resident / Student
Health Professional (non-physician)
Industry
Researcher / Basic Science

Education Level
Advanced / Expert
Beginner / Foundational
Intermediate / Experienced

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice